Ovarian Cancer

Ovarian cancer develops in one or both ovaries and ranks among the most serious gynaecological cancers, partly because symptoms are vague and the disease is often caught late. It accounts for a meaningful share of cancer-related deaths in women across East and Southeast Asia, including Japan, South Korea, and Singapore, where incidence has been rising alongside westernised diets and delayed childbearing.

Medicine used to treat Ovarian Cancer

Alkacel

Melphalan

2mg

Formulated to address malignant cell proliferation by supporting the alkylation of DNA and inhibiting cellular replication.

From $5.52 / tablet View

How ovarian cancer is managed

Treatment almost always begins with surgery to remove as much tumour as possible, followed by chemotherapy to eliminate remaining cells. Alkylating agents such as melphalan have a long history in ovarian cancer protocols, working by cross-linking DNA strands to stop cancer cells from dividing. Broader oncology support resources can help patients understand the range of medicines involved across different regimens.

Persistent bloating, pelvic pressure, early satiety, or unexplained changes in urinary habits warrant prompt gynaecological assessment, especially in women over 50 or those with a family history of ovarian or breast cancer.